Position in NVO
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$1,216,141
+$184,018 QoQ
Shares Held
25,368
-9.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#481
of 1,348 holders
Holding Since
Mar 2022
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BURNEY CO/ holds $61,483,180 across 10 Drug Manufacturers - General names. NVO ranks #7 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
24,397 | $29,262,496 | |
| 2 | ABBV |
AbbVie Inc.
|
45,639 | $11,484,597 | |
| 3 | JNJ |
Johnson & Johnson
|
28,586 | $7,259,986 | |
| 4 | AMGN |
Amgen Inc
|
16,862 | $6,106,067 | |
| 5 | MRK |
Merck & Co., Inc.
|
16,615 | $2,135,027 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
25,296 | $1,457,555 | |
| 7 | NVO |
Novo Nordisk A S
This page
|
25,368 | $1,216,141 | |
| 8 | PFE |
Pfizer Inc
|
38,365 | $923,829 |
All Filings in NVO
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,216,141 | 25,368 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $1,032,123 | 28,085 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $1,374,268 | 27,010 | Shares | Sole | 2026-01-23 | |
| 2024-09-30 | $228,733 | 1,921 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $274,203 | 1,921 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $242,804 | 1,891 | Shares | Sole | 2024-05-22 | |
| 2022-03-31 | $302,944 | 2,728 | Shares | Sole | 2022-05-09 | |
| No filing history on record for this holder in this stock. | ||||||